Youcare Pharmaceutical Group Co (SHSE:688658) Piotroski F-Score: 3 (As of Jul. 16, 2026) — 25% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688658 Youcare Pharmaceutical Group Co Ltd SHSE:688658
52 GF Score
Price ¥13.11
GF Value ¥11.05
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Youcare Pharmaceutical Group Co Piotroski F-Score?

Youcare Pharmaceutical Group Co SHSE:688658 -9.59% 52 Piotroski F-Score is 3 as of Jul. 16, 2026, which is 25% below its 10-year median of 4.00. GuruFocus rates SHSE:688658 with a GF Score™ of 52/100 and a GF Value™ of ¥11.05 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 1,333 Biotechnology companies, Youcare Pharmaceutical Group Co ranks better than 54.69% on this metric.

Warning Sign:

Piotroski F-Score of 3 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Youcare Pharmaceutical Group Co has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Youcare Pharmaceutical Group Co's Piotroski F-Score or its related term are showing as below:

SHSE:688658' s Piotroski F-Score Range Over the Past 10 Years
Min: 1   Med: 4   Max: 7
Current: 3

During the past 9 years, the highest Piotroski F-Score of Youcare Pharmaceutical Group Co was 7. The lowest was 1. And the median was 4.

Youcare Pharmaceutical Group Co  (SHSE:688658) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Youcare Pharmaceutical Group Co Piotroski F-Score Related Terms


Youcare Pharmaceutical Group Co Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Youcare Pharmaceutical Group Co's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Youcare Pharmaceutical Group Co Piotroski F-Score Chart

Youcare Pharmaceutical Group Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only 4.00 1.00 4.00 5.00 3.00

Youcare Pharmaceutical Group Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 3.00 3.00 3.00 3.00

SHSE:688658 vs VRTX, REGN, ALNY: Piotroski F-Score Comparison

For the Biotechnology subindustry, Youcare Pharmaceutical Group Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Youcare Pharmaceutical Group Co Piotroski F-Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Youcare Pharmaceutical Group Co's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Youcare Pharmaceutical Group Co's Piotroski F-Score falls into.


SHSE:688658
52GF Score
Youcare Pharmaceutical Group Co Ltd SHSE:688658
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was -49.558 + -49.149 + -114.412 + -33.106 = ¥-246 Mil.
Cash Flow from Operations was -88.264 + 175.557 + 171.952 + 44.47 = ¥304 Mil.
Revenue was 589.999 + 591.724 + 686.981 + 556.037 = ¥2,425 Mil.
Gross Profit was 320.111 + 290.95 + 358.124 + 316.547 = ¥1,286 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(5611.332 + 5289.331 + 5229.703 + 5199.572 + 5187.151) / 5 = ¥5303.4178 Mil.
Total Assets at the begining of this year (Mar25) was ¥5,611 Mil.
Long-Term Debt & Capital Lease Obligation was ¥496 Mil.
Total Current Assets was ¥2,518 Mil.
Total Current Liabilities was ¥1,277 Mil.
Net Income was 49.248 + 91.172 + -86.008 + -49.271 = ¥5 Mil.

Revenue was 982.136 + 1041.759 + 789.08 + 577.383 = ¥3,390 Mil.
Gross Profit was 624.976 + 669.44 + 378.996 + 258.557 = ¥1,932 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(6109.037 + 5856.067 + 6003.71 + 5738.112 + 5611.332) / 5 = ¥5863.6516 Mil.
Total Assets at the begining of last year (Mar24) was ¥6,109 Mil.
Long-Term Debt & Capital Lease Obligation was ¥550 Mil.
Total Current Assets was ¥3,038 Mil.
Total Current Liabilities was ¥1,402 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Youcare Pharmaceutical Group Co's current Net Income (TTM) was -246. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Youcare Pharmaceutical Group Co's current Cash Flow from Operations (TTM) was 304. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=-246.225/5611.332
=-0.04387996

ROA (Last Year)=Net Income/Total Assets (Mar24)
=5.141/6109.037
=0.00084154

Youcare Pharmaceutical Group Co's return on assets of this year was -0.04387996. Youcare Pharmaceutical Group Co's return on assets of last year was 0.00084154. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Youcare Pharmaceutical Group Co's current Net Income (TTM) was -246. Youcare Pharmaceutical Group Co's current Cash Flow from Operations (TTM) was 304. ==> 304 > -246 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=496.493/5303.4178
=0.09361755

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=550.138/5863.6516
=0.09382174

Youcare Pharmaceutical Group Co's gearing of this year was 0.09361755. Youcare Pharmaceutical Group Co's gearing of last year was 0.09382174. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=2518.471/1277.091
=1.97203723

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=3037.808/1401.752
=2.16715082

Youcare Pharmaceutical Group Co's current ratio of this year was 1.97203723. Youcare Pharmaceutical Group Co's current ratio of last year was 2.16715082. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Youcare Pharmaceutical Group Co's number of shares in issue this year was 472.943. Youcare Pharmaceutical Group Co's number of shares in issue last year was 447.919. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=1285.732/2424.741
=0.5302554

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=1931.969/3390.358
=0.56984218

Youcare Pharmaceutical Group Co's gross margin of this year was 0.5302554. Youcare Pharmaceutical Group Co's gross margin of last year was 0.56984218. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=2424.741/5611.332
=0.43211505

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=3390.358/6109.037
=0.55497421

Youcare Pharmaceutical Group Co's asset turnover of this year was 0.43211505. Youcare Pharmaceutical Group Co's asset turnover of last year was 0.55497421. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+1+0+1+1+0+0+0+0
=3

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Youcare Pharmaceutical Group Co has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 3 mean?
Youcare Pharmaceutical Group Co (SHSE:688658) has a Piotroski F-Score of 3 as of Jul. 16, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Youcare Pharmaceutical Group Co and its competitors. This is 25% below median its historical median of 4.00. Over the past decade, Youcare Pharmaceutical Group Co's Piotroski F-Score has ranged from 1.00 to 7.00. According to the industry distribution chart, Youcare Pharmaceutical Group Co ranks #604 out of 1333 companies in the Biotechnology industry, placing it in the top 45.3%.
Is Youcare Pharmaceutical Group Co's Piotroski F-Score too high?
Youcare Pharmaceutical Group Co's current Piotroski F-Score of 3 is 25% below median its 10-year median of 4.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 7.00. The Biotechnology industry median Piotroski F-Score is 3.00. Youcare Pharmaceutical Group Co's value of 3 is 0% at this industry median. Based on the distribution chart, Youcare Pharmaceutical Group Co ranks #604 out of 1333 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Youcare Pharmaceutical Group Co has a GF Score™ of 52/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Youcare Pharmaceutical Group Co's Piotroski F-Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Youcare Pharmaceutical Group Co ranks #604 out of 1333 companies for Piotroski F-Score. This puts Youcare Pharmaceutical Group Co in the upper half of its industry. The industry median Piotroski F-Score is 3.00. Youcare Pharmaceutical Group Co's value of 3 is 0% at this benchmark. Historically, Youcare Pharmaceutical Group Co's own Piotroski F-Score has ranged from 1.00 to 7.00 over the past decade. While the company's 10-year median is 4.00 vs. the industry median of 3.00, Youcare Pharmaceutical Group Co has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Biotechnology company?
The median Piotroski F-Score among Biotechnology companies is 3.00, based on 1,333 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Youcare Pharmaceutical Group Co's current Piotroski F-Score of 3 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Youcare Pharmaceutical Group Co and its competitors. For the Biotechnology industry, the median Piotroski F-Score is 3.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Youcare Pharmaceutical Group Co's current Piotroski F-Score is 3, which is 25% below median its own 10-year median of 4.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Youcare Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Youcare Pharmaceutical Group Co (SHSE:688658) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥11.05, compared to a current price of ¥13.11 — trading 18.6% above its estimated fair value. The current Piotroski F-Score is 3, which is 25% below median its 10-year median of 4.00 and 0% at the Biotechnology industry median of 3.00. Youcare Pharmaceutical Group Co's overall GF Score™ is 52/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Youcare Pharmaceutical Group Co (SHSE:688658), the current Piotroski F-Score is 3 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Youcare Pharmaceutical Group Co (SHSE:688658) Overvalued in 2026?

Based on GuruFocus' analysis, Youcare Pharmaceutical Group Co stock appears to be overvalued. The current stock price of ¥13.11 is trading 18.6% above its estimated GF Value™ of ¥11.05. GuruFocus considers Youcare Pharmaceutical Group Co to be Modestly Overvalued.

Key valuation signals for SHSE:688658:

  • Piotroski F-Score: 3 (25% below median its 10-year median of 4.00)
  • GF Value™: ¥11.05 vs. price of ¥13.11 (18.6% above fair value)
  • GF Score™: 52/100 with 6 warning signs
  • Industry Position: 0% at the Biotechnology median (#604 of 1333)

No single metric tells the full story. See the SHSE:688658 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Youcare Pharmaceutical Group Co Business Description

Address No. 6, Hongda Middle Road, Beijing Economic and Technological Development Zone, Beijing, CHN, 100176
Youcare Pharmaceutical Group Co Ltd is a pharmaceutical group enterprise integrating new drug research and development, drug production, circulation and sales.
52GF Score

Get the complete analysis for SHSE:688658

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥13.11
Price
¥11.05
GF Value